News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
873,507 Results
Type
Article (88192)
Company Profile (825)
Press Release (784470)
Multimedia
Podcasts (207)
Webinars (32)
Section
Business (233353)
Career Advice (4152)
Deals (39897)
Drug Delivery (157)
Drug Development (91479)
Employer Resources (205)
FDA (18439)
Job Trends (17441)
News (398137)
Policy (39997)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3023)
Academic (2)
Accelerated approval (41)
Adcomms (36)
Allergies (165)
Alliances (56982)
ALS (191)
Alzheimer's disease (1826)
Antibody-drug conjugate (ADC) (379)
Approvals (18640)
Artificial intelligence (684)
Autoimmune disease (200)
Automation (48)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (212)
Biotechnology (491)
Bladder cancer (176)
Brain cancer (69)
Breast cancer (696)
Cancer (5357)
Cardiovascular disease (474)
Career advice (3579)
Career pathing (43)
CAR-T (318)
CDC (68)
Celiac Disease (2)
Cell therapy (877)
Cervical cancer (40)
Clinical research (77430)
Collaboration (1963)
Company closure (6)
Compensation (1239)
Complete response letters (82)
COVID-19 (3005)
CRISPR (110)
C-suite (971)
Cystic fibrosis (157)
Data (6703)
Decentralized trials (2)
Denatured (76)
Depression (163)
Diabetes (556)
Diagnostics (7331)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (332)
Drug pricing (230)
Drug shortages (36)
Duchenne muscular dystrophy (258)
Earnings (100760)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (135899)
Executive appointments (1073)
FDA (21817)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1652)
Gene editing (234)
Generative AI (71)
Gene therapy (722)
GLP-1 (1170)
Government (5484)
Grass and pollen (8)
Guidances (389)
Healthcare (20984)
HIV (76)
Huntington's disease (54)
IgA nephropathy (90)
Immunology and inflammation (312)
Immuno-oncology (76)
Indications (134)
Infectious disease (3323)
Inflammatory bowel disease (219)
Inflation Reduction Act (17)
Influenza (134)
Intellectual property (268)
Interviews (817)
IPO (17971)
IRA (61)
Job creations (5202)
Job search strategy (2868)
JPM (73)
Kidney cancer (20)
Labor market (99)
Layoffs (663)
Leadership (44)
Legal (10168)
Liver cancer (102)
Longevity (20)
Lung cancer (717)
Lymphoma (396)
Machine learning (49)
Management (66)
Manufacturing (929)
MASH (184)
Medical device (15097)
Medtech (15163)
Mergers & acquisitions (23044)
Metabolic disorders (1484)
mRNA (201)
Multiple sclerosis (179)
NASH (23)
Neurodegenerative disease (386)
Neuropsychiatric disorders (108)
Neuroscience (3251)
Neurotech (1)
NextGen: Class of 2026 (7710)
Non-profit (5124)
Now hiring (70)
Obesity (725)
Opinion (349)
Ovarian cancer (176)
Pain (232)
Pancreatic cancer (254)
Parkinson's disease (317)
Partnered (39)
Patents (548)
Patient recruitment (555)
Peanut (65)
People (67167)
Pharmaceutical (145)
Pharmacy benefit managers (34)
Phase 1 (23923)
Phase 2 (33596)
Phase 3 (25315)
Pipeline (6149)
Policy (359)
Postmarket research (3554)
Preclinical (10727)
Press Release (72)
Prostate cancer (273)
Psychedelics (60)
Radiopharmaceuticals (318)
Rare diseases (1022)
Real estate (7445)
Recruiting (81)
Regulatory (29367)
Reports (69)
Research institute (2746)
Resumes & cover letters (653)
Rett syndrome (31)
RNA editing (21)
RSV (90)
Schizophrenia (166)
Series A (278)
Series B (206)
Service/supplier (30)
Sickle cell disease (110)
Special edition (29)
Spinal muscular atrophy (179)
Sponsored (49)
Startups (4340)
State (2)
Stomach cancer (21)
Supply chain (120)
Tariffs (101)
The Weekly (129)
Vaccines (1193)
Venture capital (103)
Weight loss (496)
Women's health (106)
Worklife (23)
Date
Today (153)
Last 7 days (878)
Last 30 days (3253)
Last 365 days (32820)
2026 (5820)
2025 (33228)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (95)
Alaska (7)
Arizona (355)
Arkansas (15)
Asia (51701)
Australia (9085)
California (12238)
Canada (3477)
China (1234)
Colorado (517)
Connecticut (535)
Delaware (363)
Europe (118974)
Florida (1817)
Georgia (397)
Hawaii (4)
Idaho (68)
Illinois (1022)
India (81)
Indiana (574)
Iowa (24)
Japan (470)
Kansas (135)
Kentucky (49)
Louisiana (35)
Maine (84)
Maryland (1521)
Massachusetts (8979)
Michigan (381)
Minnesota (687)
Mississippi (7)
Missouri (146)
Montana (36)
Nebraska (30)
Nevada (134)
New Hampshire (88)
New Jersey (3284)
New Mexico (33)
New York (3219)
North Carolina (1689)
North Dakota (10)
Northern California (5919)
Ohio (377)
Oklahoma (23)
Oregon (55)
Pennsylvania (2436)
Puerto Rico (25)
Rhode Island (52)
South America (1665)
South Carolina (70)
South Dakota (1)
Southern California (4744)
Tennessee (193)
Texas (1923)
United States (44018)
Utah (370)
Vermont (1)
Virginia (308)
Washington D.C. (88)
Washington State (1012)
West Virginia (4)
Wisconsin (140)
Wyoming (2)
There are 873,507 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Supply chain
FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP-1s
Having targeted Hims & Hers last year, the FDA has issued warnings to more telehealth companies over their promotion of GLP-1 drugs used to treat diabetes and obesity. In one case, compounded products were linked with multiple ER visits.
March 4, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center
March 4, 2026
·
3 min read
Press Releases
Exact Sciences Named Gallup Exceptional Workplace Award Winner for Third Consecutive Year
March 4, 2026
·
2 min read
Press Releases
BoomRx Surpasses $15.5 Million in Net Order Revenue and 77,000+ Processed Orders in First Eight Months
March 4, 2026
·
3 min read
Press Releases
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM) - March 4, 2026
March 4, 2026
·
12 min read
Press Releases
MannKind to Participate in Upcoming March 2026 Investor Conferences
March 4, 2026
·
1 min read
Press Releases
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
March 4, 2026
·
5 min read
Press Releases
QT Imaging Names Renowned Breast Cancer Researcher Dr. Mary Yamashita as Medical Advisor
March 4, 2026
·
7 min read
Press Releases
Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma
March 4, 2026
·
6 min read
Press Releases
Ensysce Biosciences Initiates Live “Ask Me Anything” (AMA) Session Highlighting Growth and Future Plans
March 4, 2026
·
4 min read
1 of 87,351
Next
